Mycoepoxydiene suppresses RANKL-induced osteoclast differentiation and reduces ovariectomy-induced bone loss in mice

Applied Microbiology and Biotechnology

Volumn 97, Issue 2, 2013, Pages 767-774

  Zhu, Jingwei ^a   Chen, Qiang ^a   Xia, Xiaochun ^a   Mo, Pingli ^a   Shen, Yuemao ^b   Yu, Chundong ^a  

^a XIAMEN UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

ERK1 2; Mycoepoxydiene; NF kB; NFATc1; Osteoclast differentiation

Indexed keywords

ERK1/2; MYCOEPOXYDIENE; NF-KB; NFATC1; OSTEOCLAST DIFFERENTIATION;

CHEMICAL ACTIVATION; DISEASES; GYNECOLOGY; LEAD COMPOUNDS; MAMMALS; PHOSPHATASES; PHOSPHORYLATION;

BONE;

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; CALCITONIN RECEPTOR; CATHEPSIN K; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 3; MYCOEPOXYDIENE; OSTEOCLAST DIFFERENTIATION FACTOR; POLYKETIDE; UNCLASSIFIED DRUG;

BONE; CHEMICAL COMPOUND; DRUG DEVELOPMENT; FUNGUS; GENE EXPRESSION; GENETIC ANALYSIS; MARINE ENVIRONMENT; RODENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE ATROPHY; BONE MARROW; CONTROLLED STUDY; FEMALE; IN VITRO STUDY; MACROPHAGE; MOUSE; NONHUMAN; OSTEOCLASTOGENESIS; OSTEOLYSIS; OVARIECTOMY; PROTEIN EXPRESSION; T LYMPHOCYTE;

ANIMALS; BONE MARROW CELLS; BONE RESORPTION; BRIDGED COMPOUNDS; CELL DIFFERENTIATION; CELLS, CULTURED; FEMALE; MICE; OSTEOCLASTS; OVARIECTOMY; PYRONES; RANK LIGAND;

DIAPORTHE; MUS; RHIZOPHORACEAE;

EID: 84873998657     PISSN: 01757598     EISSN: 14320614     Source Type: Journal    
DOI: 10.1007/s00253-012-4146-5     Document Type: Article

References (36)

1. Arai F, Miyamoto T, Ohneda O, Inada T, Sudo T, Brasel K, Miyata T, Anderson DM, Suda T (1999) Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor kappaB (RANK) receptors. J Exp Med 190:1741-1754
2. Asagiri M, Takayanagi H (2007) The molecular understanding of osteoclast differentiation. Bone 40:251-264
3. Asagiri M, Sato K, Usami T, Ochi S, Nishina H, Yoshida H, Morita I, Ef W, Tw M, Serfling E, Takayanagi H (2005) Autoamplification of NFATc1 expression determines its essential role in bone homeostasis. J Exp Med 202:1261-1269
4. Baron R (2004) Arming the osteoclast. Nat Med 10:458-460
5. Boyle WJ, Simonet WS, Lacey DL (2003) Osteoclast differentiation and activation. Nature 423:337-342
6. Chen J, Sun Y, Mao X, Liu Q, Wu H, Chen Y (2010) RANKL up-regulates brain-type creatine kinase via poly(ADP-ribose) polymerase-1 during osteoclastogenesis. J Biol Chem 285:36315-36321
7. Darnay BG, Ni J, Moore PA, Aggarwal BB (1999) Activation of NF-kappaB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-kappaB-inducing kinase. Identification of a novel TRAF6 interaction motif. J Biol Chem 274:7724-7731
8. Franzoso G, Carlson L, Xing L, Poljak L, Ew S, Kd B, Leonardi A, Tran T, Bf B, Siebenlist U (1997) Requirement for NF-kappaB in osteoclast and B-cell development. Genes Dev 11:3482-3496
9. He Y, Staser K, Sd R, Liu Y, Wu X, Sj P, Yuan J, Yang X, Li X, Jiang L, Chen S, Fc Y (2011a) Erk1 positively regulates osteoclast differentiation and bone resorptive activity. PLoS One 6:e24780
10. He YX, Zhang G, Pan Xh, Liu Z, Lz Z, Cw C, Km L, Yp C, Li G, Wei L, Lk H, Ks L, Qin L (2011b) Impaired bone healing pattern in mice with ovariectomy-induced osteoporosis: a drill-hole defect model. Bone 48:1388-1400
11. Hirata K, Taki H, Shinoda K, Hounoki H, Miyahara T, Tobe K, Ogawa H, Mori H, Sugiyama E (2010) Inhibition of tumor progression locus 2 protein kinase suppresses receptor activator of nuclear factor-kappaB ligand-induced osteoclastogenesis through down-regulation of the c-Fos and nuclear factor of activated T cells c1 genes. Biol Pharm Bull 33:133-137
12. Hirotani H, Na T, Jt W, Stern Ph, Na C (2004) The calcineurin/nuclear factor of activated T cells signaling pathway regulates osteoclastogenesis in RAW264.7 cells. J Biol Chem 279:13984-13992
13. Huber DM, Ac B, Pathrose P, Srivastava S, Km D, Nk S, Jw P (2001) Androgens suppress osteoclast formation induced by RANKL and macrophage-colony stimulating factor. Endocrinology 142:3800-3808
14. Ishida N, Hayashi K, Hoshijima M, Ogawa T, Koga S, Miyatake Y, Kumegawa M, Kimura T, Takeya T (2002) Large scale gene expression analysis of osteoclastogenesis in vitro and elucidation of NFAT2 as a key regulator. J Biol Chem 277:41147-41156
15. Jiang J, Li H, Fs F, Filbert E, Ke S, Ls S, Zhu Q (2006) Quantitative analysis of osteoclast-specific gene markers stimulated by lipopolysaccharide. J Endod 32:742-746
16. Kobayashi N, Kadono Y, Naito A, Matsumoto K, Yamamoto T, Tanaka S, Inoue J (2001) Segregation of TRAF6-mediated signaling pathways clarifies its role in osteoclastogenesis. EMBO J 20:1271-1280
17. Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, Capparelli C, Morony S, Oliveira-Dos-Santos AJ, Van G, Itie A, Khoo W, Wakeham A, Dunstan CR, Lacey DL, Mak TW, Boyle WJ, Penninger JM (1999) OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397:315-323
18. Lin X, Huang Y, Fang M, Wang J, Zheng Z, Su W (2005) Cytotoxic and antimicrobial metabolites from marine lignicolous fungi, Diaporthe sp. FEMS Microbiol Lett 251:53-58
19. Mellis DJ, Itzstein C, Helfrich Mh, Jc C (2011) The skeleton: a multi-functional complex organ: the role of key signalling pathways in osteoclast differentiation and in bone resorption. J Endocrinol 211:131-143
20. Miyamoto T, Suda T (2003) Differentiation and function of osteoclasts. Keio J Med 52:1-7
21. Miyazaki T, Katagiri H, Kanegae Y, Takayanagi H, Sawada Y, Yamamoto A, Mp P, Asano T, Im V, Oda H, Nakamura K, Tanaka S (2000) Reciprocal role of ERK and NF-kappaB pathways in survival and activation of osteoclasts. J Cell Biol 148:333-342
22. Nakamura H, Hirata A, Tsuji T, Yamamoto T (2003) Role of osteoclast extracellular signal-regulated kinase (ERK) in cell survival and maintenance of cell polarity. J Bone Miner Res 18:1198-1205
23. Nakashima T, Hayashi M, Fukunaga T, Kurata K, Oh-Hora M, Jq F, Lf B, Kodama T, Wutz A, Ef W, Jm P, Takayanagi H (2011) Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat Med 17:1231-1234
24. Omata Y, Tanaka S (2011) RANKL/RANK signaling in rheumatoid arthritis. Clin Calcium 21:1175-1180
25. Remen KM, Henning P, Lerner Uh, Gustafsson JA, Andersson G (2011) Activation of liver X receptor (LXR) inhibits receptor activator of nuclear factor kappaB ligand (RANKL)-induced osteoclast differentiation in an LXRbeta-dependent mechanism. J Biol Chem 286:33084-33094
26. Suda T, Kobayashi K, Jimi E, Udagawa N, Takahashi N (2001) The molecular basis of osteoclast differentiation and activation. Novartis Found Symp 232:235-247, discussion 247-250
27. Takami M, Es C, Sy L, Kamijo R, Yim M (2005) Phosphodiesterase inhibitors stimulate osteoclast formation via TRANCE/RANKL expression in osteoblasts: possible involvement of ERK and p38 MAPK pathways. FEBS Lett 579:832-838
28. Takao K, Watanabe G, Yasui H, Tadano K (2002) Total synthesis of (+/-)-mycoepoxydiene, a novel fungal metabolite having an oxygen-bridged cyclooctadiene skeleton. Org Lett 4:2941-2943
29. Takatsuna H, Asagiri M, Kubota T, Oka K, Osada T, Sugiyama C, Saito H, Aoki K, Ohya K, Takayanagi H, Umezawa K (2005) Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-kappaB inhibitor, through downregulation of NFATc1. J Bone Miner Res 20:653-662
30. Takayanagi H (2005) Inflammatory bone destruction and osteoimmunology. J Periodontal Res 40:287-293
31. Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, Yoshida H, Saiura A, Isobe M, Yokochi T, Inoue J, Ef W, Tw M, Kodama T, Taniguchi T (2002) Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell 3:889-901
32. Teitelbaum SL (2000) Bone resorption by osteoclasts. Science 289:1504-1508
33. Uchida R, Chiba H, Ishimi Y, Uehara M, Suzuki K, Kim H, Matsumoto A (2011) Combined effects of soy isoflavone and fish oil on ovariectomy-induced bone loss in mice. J Bone Miner Metab 29:404-413
34. Wang J, Zhao B, Zhang W, Wu X, Wang R, Huang Y, Chen D, Park K, Bc W, Shen Y (2010) Mycoepoxydiene, a fungal polyketide, induces cell cycle arrest at the G2/M phase and apoptosis in HeLa cells. Bioorg Med Chem Lett 20:7054-7058
35. Wiktor-Jedrzejczak W, Bartocci A, Aw Ferrante Jr, Ahmed-Ansari A, Sell Kw, Pollard Jw, Stanley Er (1990) Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse. Proc Natl Acad Sci U S A 87:4828-4832
36. Yamashita M, Otsuka F, Mukai T, Yamanaka R, Otani H, Matsumoto Y, Nakamura E, Takano M, Ke S, Makino H (2010) Simvastatin inhibits osteoclast differentiation induced by bone morphogenetic protein-2 and RANKL through regulating MAPK, AKT and Src signaling. Regul Pept 162:99-108